{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:42:25Z","timestamp":1791013345318,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Guillain\u2013Barr\u00e9 syndrome (GBS) is an acute autoimmune polyneuropathy with substantial geographic variations in demography, antecedent events, clinical manifestations, electrophysiological sub-types, diagnostic findings, treatment modalities, and prognostic indicators. However, there is limited contemporary data on GBS patient profiles and prognostic factors from low-resource settings like Ethiopia. The objective of this study is to investigate the clinical profile, factors associated with mortality, and hospital outcomes among GBS patients admitted to Tikur Anbessa Specialized Hospital (TASH) in Addis Ababa, Ethiopia. A retrospective cross-sectional study was conducted among 60 GBS patients admitted to TASH from January 2018 to December 2022. Data on demographics, clinical features, treatments, complications, and outcomes were extracted from medical records. Bivariate and multivariate logistic regression analyses identified factors associated with mortality and poor hospital outcomes. The cohort had a mean age of 28.5\u00a0years, with 76.7% aged 14\u201334\u00a0years. Males comprised 61.7% of cases. Ascending paralysis (76.7%) was the predominant presentation. Absent or reduced reflexes were seen in 91.7% of patients. The most common antecedent event was gastroenteritis (26.7%), followed by upper respiratory tract infection (URTI) (15%) and vaccination (11.7%). The mean interval from symptom onset to hospital presentation was 8.77\u00a0days, and the peak symptom severity was 4.47\u00a0days. The axonal variant (75.5%) was the most common subtype, followed by the demyelinating variant (24.5%). Intravenous immunoglobulin was administered to 41.7% of patients. Respiratory failure requiring invasive mechanical ventilator (MV) support occurred in 26.7% of cases. The mortality rate was 10%, with mechanical ventilation being the only factor significantly associated with mortality (95% CI 2.067\u2013184.858; P\u2009&lt;\u20090.010). At discharge, 55% had a good outcome, and 45% had a poor outcome, according to the Hughes Functional Disability Scale (HFDS). Mechanical ventilation (AOR 0.024, 95% CI 0.001\u20130.607) and a GBS disability score\u2009&gt;\u20093 (AOR 0.106, 95% CI 0.024\u20130.467) were factors significantly associated with poor hospital outcomes. GBS in this cohort primarily affected individuals of young age, commonly preceded by gastroenteritis and characterized by a high frequency of the axonal variant. Mechanical ventilation was found to be significantly linked to mortality. Alongside mechanical ventilation requirements, severe disability upon presentation emerged as a crucial determinant of poor outcomes upon discharge, underscoring the importance of early identification of high-risk patients and prompt interventions.<\/jats:p>","DOI":"10.1038\/s41598-024-65265-0","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T14:53:10Z","timestamp":1720191190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A retrospective analysis of the clinical profile and factors associated with mortality and poor hospital outcomes in adult Guillain\u2013Barre syndrome patients"],"prefix":"10.1038","volume":"14","author":[{"given":"Zinabu Derso","family":"Tewedaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawit Kebede","family":"Huluka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabets Tesfaye","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel Tezera","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meksud Shemsu","family":"Hussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekri Delil","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leja Hamza","family":"Juhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"issue":"8","key":"65265_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"B van den Berg","year":"2014","unstructured":"van den Berg, B. et al. Guillain\u2013Barr\u00e9 syndrome: Pathogenesis, diagnosis, treatment and prognosis. Nat. Rev. Neurol. 10(8), 469\u2013482. https:\/\/doi.org\/10.1038\/nrneurol.2014.121 (2014).","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"65265_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1212\/01.wnl.0000316393.54258.d1","volume":"71","author":"PD Frenzen","year":"2008","unstructured":"Frenzen, P. D. Economic cost of Guillain\u2013Barr\u00e9 syndrome in the United States. Neurology 71(1), 21\u201327. https:\/\/doi.org\/10.1212\/01.wnl.0000316393.54258.d1 (2008).","journal-title":"Neurology"},{"issue":"2","key":"65265_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3988\/jcn.2021.17.2.257","volume":"17","author":"A-Y Kim","year":"2021","unstructured":"Kim, A.-Y., Lee, H., Lee, Y.-M. & Kang, H.-Y. Epidemiological features and economic burden of Guillain\u2013Barr\u00e9 syndrome in South Korea: A nationwide population-based study. J. Clin. Neurol. Seoul Korea 17(2), 257\u2013264. https:\/\/doi.org\/10.3988\/jcn.2021.17.2.257 (2021).","journal-title":"J. Clin. Neurol. Seoul Korea"},{"issue":"11","key":"65265_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.paed.2019.07.008","volume":"29","author":"N Abbassi","year":"2019","unstructured":"Abbassi, N. & Ambegaonkar, G. Guillain\u2013Barre syndrome: A review. Paediatr. Child Health 29(11), 459\u2013462. https:\/\/doi.org\/10.1016\/j.paed.2019.07.008 (2019).","journal-title":"Paediatr. Child Health"},{"issue":"10","key":"65265_CR5","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/brain\/awy232","volume":"141","author":"AY Doets","year":"2018","unstructured":"Doets, A. Y. et al. Regional variation of Guillain\u2013Barr\u00e9 syndrome. Brain J. Neurol. 141(10), 2866\u20132877. https:\/\/doi.org\/10.1093\/brain\/awy232 (2018).","journal-title":"Brain J. Neurol."},{"key":"65265_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.clinph.2021.12.014","volume":"138","author":"S Arends","year":"2022","unstructured":"Arends, S. et al. Electrodiagnosis of Guillain\u2013Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values. Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol. 138, 231\u2013240. https:\/\/doi.org\/10.1016\/j.clinph.2021.12.014 (2022).","journal-title":"Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol."},{"issue":"11","key":"65265_CR7","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1136\/jnnp-2014-309056","volume":"86","author":"AJS Webb","year":"2015","unstructured":"Webb, A. J. S., Brain, S. A. E., Wood, R., Rinaldi, S. & Turner, M. R. Seasonal variation in Guillain\u2013Barr\u00e9 syndrome: A systematic review, meta-analysis and Oxfordshire cohort study. J. Neurol. Neurosurg. Psychiatry 86(11), 1196\u20131201. https:\/\/doi.org\/10.1136\/jnnp-2014-309056 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"65265_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.831890","author":"J Yao","year":"2022","unstructured":"Yao, J., Liu, Y., Liu, S. & Lu, Z. Regional differences of Guillain\u2013Barr\u00e9 syndrome in China: From south to north. Front. Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2022.831890 (2022).","journal-title":"Front. Aging Neurosci."},{"issue":"12","key":"65265_CR9","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1002\/acn3.50946","volume":"6","author":"Y Hao","year":"2019","unstructured":"Hao, Y. et al. Antecedent infections in Guillain\u2013Barr\u00e9 syndrome: A single-center, prospective study. Ann. Clin. Transl. Neurol. 6(12), 2510. https:\/\/doi.org\/10.1002\/acn3.50946 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"5","key":"65265_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41582-021-00467-y","volume":"17","author":"N Papri","year":"2021","unstructured":"Papri, N. et al. Guillain\u2013Barr\u00e9 syndrome in low-income and middle-income countries: Challenges and prospects. Nat. Rev. Neurol. 17(5), 285\u2013296. https:\/\/doi.org\/10.1038\/s41582-021-00467-y (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"65265_CR11","doi-asserted-by":"publisher","first-page":"5703279","DOI":"10.1155\/2018\/5703279","volume":"2018","author":"Y Gao","year":"2018","unstructured":"Gao, Y. et al. Serum folate correlates with severity of Guillain\u2013Barr\u00e9 syndrome and predicts disease progression. BioMed Res. Int. 2018, 5703279. https:\/\/doi.org\/10.1155\/2018\/5703279 (2018).","journal-title":"BioMed Res. Int."},{"key":"65265_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2019.100015","volume":"2","author":"Y Acosta-Ampudia","year":"2019","unstructured":"Acosta-Ampudia, Y., Monsalve, D. M. & Ram\u00edrez-Santana, C. Identifying the culprits in neurological autoimmune diseases. J. Transl. Autoimmun. 2, 100015. https:\/\/doi.org\/10.1016\/j.jtauto.2019.100015 (2019).","journal-title":"J. Transl. Autoimmun."},{"issue":"5","key":"65265_CR13","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s12031-020-01720-7","volume":"71","author":"A Safa","year":"2021","unstructured":"Safa, A., Azimi, T., Sayad, A., Taheri, M. & Ghafouri-Fard, S. A review of the role of genetic factors in Guillain\u2013Barr\u00e9 syndrome. J. Mol. Neurosci. MN 71(5), 902\u2013920. https:\/\/doi.org\/10.1007\/s12031-020-01720-7 (2021).","journal-title":"J. Mol. Neurosci. MN"},{"issue":"Pt 1","key":"65265_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke, C. et al. Diagnosis of Guillain\u2013Barr\u00e9 syndrome and validation of Brighton criteria. Brain J. Neurol. 137(Pt 1), 33\u201343. https:\/\/doi.org\/10.1093\/brain\/awt285 (2014).","journal-title":"Brain J. Neurol."},{"issue":"8093","key":"65265_CR15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"312","author":"RAC Hughes","year":"1978","unstructured":"Hughes, R. A. C., Newsom-Davis, J. M., Perkin, G. D. & Pierce, J. M. Controlled trial of prednisolone in acute polyneuropathy. Lancet 312(8093), 750\u2013753. https:\/\/doi.org\/10.1016\/S0140-6736(78)92644-2 (1978).","journal-title":"Lancet"},{"issue":"7","key":"65265_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","volume":"6","author":"R van Koningsveld","year":"2007","unstructured":"van Koningsveld, R. et al. A clinical prognostic scoring system for Guillain\u2013Barr\u00e9 syndrome. Lancet Neurol. 6(7), 589\u2013594. https:\/\/doi.org\/10.1016\/S1474-4422(07)70130-8 (2007).","journal-title":"Lancet Neurol."},{"issue":"1","key":"65265_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jns.2015.07.018","volume":"357","author":"YA Rajabally","year":"2015","unstructured":"Rajabally, Y. A., Hiew, F. L. & Winer, J. B. Influence of timing on electrodiagnosis of Guillain\u2013Barr\u00e9 syndrome in the first six weeks: A retrospective study. J. Neurol. Sci. 357(1), 143\u2013145. https:\/\/doi.org\/10.1016\/j.jns.2015.07.018 (2015).","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"65265_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12028-019-00781-w","volume":"32","author":"T Chakraborty","year":"2020","unstructured":"Chakraborty, T., Kramer, C. L., Wijdicks, E. F. M. & Rabinstein, A. A. Dysautonomia in Guillain\u2013Barr\u00e9 syndrome: Prevalence, clinical spectrum, and outcomes. Neurocrit. Care 32(1), 113\u2013120. https:\/\/doi.org\/10.1007\/s12028-019-00781-w (2020).","journal-title":"Neurocrit. Care"},{"issue":"3","key":"65265_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10286-018-0542-y","volume":"29","author":"Z Zaeem","year":"2019","unstructured":"Zaeem, Z., Siddiqi, Z. A. & Zochodne, D. W. Autonomic involvement in Guillain\u2013Barr\u00e9 syndrome: An update. Clin. Auton. Res. Off. J. Clin. Auton. Res. Soc. 29(3), 289\u2013299. https:\/\/doi.org\/10.1007\/s10286-018-0542-y (2019).","journal-title":"Clin. Auton. Res. Off. J. Clin. Auton. Res. Soc."},{"key":"65265_CR20","doi-asserted-by":"publisher","unstructured":"\u201cFrontiers | Disability evaluation in patients with Guillain\u2013Barre syndrome and SARS-CoV-2 infection\u201d. https:\/\/doi.org\/10.3389\/fneur.2023.1191520\/full (accessed 02 Apr 2024).","DOI":"10.3389\/fneur.2023.1191520\/full"},{"issue":"2","key":"65265_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000324710","volume":"36","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar, J. J., Baughman, A. L., Wise, M. & Morgan, O. W. Population incidence of Guillain\u2013Barr\u00e9 syndrome: A systematic review and meta-analysis. Neuroepidemiology 36(2), 123\u2013133. https:\/\/doi.org\/10.1159\/000324710 (2011).","journal-title":"Neuroepidemiology"},{"issue":"2","key":"65265_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4103\/ijmr.IJMR_995_14","volume":"145","author":"M Shrivastava","year":"2017","unstructured":"Shrivastava, M., Nehal, S. & Seema, N. Guillain\u2013Barre syndrome: Demographics, clinical profile and seasonal variation in a tertiary care centre of central India. Indian J. Med. Res. 145(2), 203\u2013208. https:\/\/doi.org\/10.4103\/ijmr.IJMR_995_14 (2017).","journal-title":"Indian J. Med. Res."},{"issue":"2","key":"65265_CR23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s00415-018-9151-x","volume":"266","author":"H Al-Hakem","year":"2019","unstructured":"Al-Hakem, H. et al. Guillain\u2013Barr\u00e9 syndrome in Denmark: A population-based study on epidemiology, diagnosis and clinical severity. J. Neurol. 266(2), 440\u2013449. https:\/\/doi.org\/10.1007\/s00415-018-9151-x (2019).","journal-title":"J. Neurol."},{"issue":"2","key":"65265_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000184748","volume":"32","author":"A McGrogan","year":"2009","unstructured":"McGrogan, A., Madle, G. C., Seaman, H. E. & de Vries, C. S. The epidemiology of Guillain\u2013Barr\u00e9 syndrome worldwide. A systematic literature review. Neuroepidemiology 32(2), 150\u2013163. https:\/\/doi.org\/10.1159\/000184748 (2009).","journal-title":"Neuroepidemiology"},{"issue":"4","key":"65265_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.18231\/2455-8451.2018.0047","volume":"4","author":"TK Ralot","year":"2020","unstructured":"Ralot, T. K., Parmar, S., Gujar, R., Sarkar, S. & Meghwal, H. Study of clinical profile and prognosis in various subtypes of Guillain\u2013Barre syndrome patients. IP Indian J. Neurosci. 4(4), 204\u2013208 (2020).","journal-title":"IP Indian J. Neurosci."},{"issue":"1\u20132","key":"65265_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jns.2013.09.002","volume":"335","author":"R Verma","year":"2013","unstructured":"Verma, R., Chaudhari, T. S., Raut, T. P. & Garg, R. K. Clinico-electrophysiological profile and predictors of functional outcome in Guillain\u2013Barre syndrome (GBS). J. Neurol. Sci. 335(1\u20132), 105\u2013111. https:\/\/doi.org\/10.1016\/j.jns.2013.09.002 (2013).","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"65265_CR27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40995","volume":"15","author":"NA AlKahtani","year":"2023","unstructured":"AlKahtani, N. A. et al. Guillain\u2013Barr\u00e9 syndrome in adults in a decade: The largest, single-center, cross-sectional study from the Kingdom of Saudi Arabia. Cureus 15(6), e40995. https:\/\/doi.org\/10.7759\/cureus.40995 (2023).","journal-title":"Cureus"},{"key":"65265_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1471-2377-13-95","volume":"13","author":"I Gonz\u00e1lez-Su\u00e1rez","year":"2013","unstructured":"Gonz\u00e1lez-Su\u00e1rez, I., Sanz-Gallego, I., Rodr\u00edguez de Rivera, F. J. & Arpa, J. Guillain\u2013Barr\u00e9 syndrome: natural history and prognostic factors: A retrospective review of 106 cases. BMC Neurol. 13, 95. https:\/\/doi.org\/10.1186\/1471-2377-13-95 (2013).","journal-title":"BMC Neurol."},{"issue":"2","key":"65265_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/CND.0000000000000176","volume":"19","author":"K Kulkantrakorn","year":"2017","unstructured":"Kulkantrakorn, K. & Sukphulloprat, P. Outcome of Guillain\u2013Barr\u00e9 syndrome in tertiary care centers in Thailand. J. Clin. Neuromuscul. Dis. 19(2), 51\u201356. https:\/\/doi.org\/10.1097\/CND.0000000000000176 (2017).","journal-title":"J. Clin. Neuromuscul. Dis."},{"issue":"4","key":"65265_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/jns.12096","volume":"19","author":"S Peric","year":"2014","unstructured":"Peric, S. et al. Clinical and epidemiological features of Guillain\u2013Barr\u00e9 syndrome in the Western Balkans. J. Peripher. Nerv. Syst. JPNS 19(4), 317\u2013321. https:\/\/doi.org\/10.1111\/jns.12096 (2014).","journal-title":"J. Peripher. Nerv. Syst. JPNS"},{"issue":"Suppl 2","key":"65265_CR31","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1086\/513793","volume":"176","author":"RA Hughes","year":"1997","unstructured":"Hughes, R. A. & Rees, J. H. Clinical and epidemiologic features of Guillain\u2013Barr\u00e9 syndrome. J. Infect. Dis. 176(Suppl 2), S92-98. https:\/\/doi.org\/10.1086\/513793 (1997).","journal-title":"J. Infect. Dis."},{"key":"65265_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.613628","volume":"12","author":"KM Hagen","year":"2021","unstructured":"Hagen, K. M. & Ousman, S. S. The neuroimmunology of Guillain\u2013Barr\u00e9 syndrome and the potential role of an aging immune system. Front. Aging Neurosci. 12, 613628. https:\/\/doi.org\/10.3389\/fnagi.2020.613628 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"65265_CR33","doi-asserted-by":"publisher","first-page":"1038411","DOI":"10.3389\/fimmu.2022.1038411","volume":"13","author":"PA McCombe","year":"2022","unstructured":"McCombe, P. A., Hardy, T. A., Nona, R. J. & Greer, J. M. Sex differences in Guillain\u2013Barr\u00e9 syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis. Front. Immunol. 13, 1038411. https:\/\/doi.org\/10.3389\/fimmu.2022.1038411 (2022).","journal-title":"Front. Immunol."},{"issue":"4","key":"65265_CR34","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/jns.12239","volume":"22","author":"JOT Sipil\u00e4","year":"2017","unstructured":"Sipil\u00e4, J. O. T., Soilu-H\u00e4nninen, M., Ruuskanen, J. O., Rautava, P. & Kyt\u00f6, V. Epidemiology of Guillain\u2013Barr\u00e9 syndrome in Finland 2004\u20132014. J. Peripher. Nerv. Syst. 22(4), 440\u2013445. https:\/\/doi.org\/10.1111\/jns.12239 (2017).","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"1","key":"65265_CR35","first-page":"1","volume":"73","author":"JMG Amante","year":"2021","unstructured":"Amante, J. M. G. & Preysler, M. G. Clinical profile and outcomes of Guillain\u2013Barre syndrome: A four-year retrospective study at a tertiary hospital in the Philippines. Clin. Profile Outcomes Guillain\u2013Barre. Syndr. Four-Year Retrosp. Study Tert. Hosp. Philipp. 73(1), 1 (2021).","journal-title":"Clin. Profile Outcomes Guillain\u2013Barre. Syndr. Four-Year Retrosp. Study Tert. Hosp. Philipp."},{"issue":"645","key":"65265_CR36","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3399\/bjgp16X684733","volume":"66","author":"VA Head","year":"2016","unstructured":"Head, V. A. & Wakerley, B. R. Guillain\u2013Barr\u00e9 syndrome in general practice: Clinical features suggestive of early diagnosis. Br. J. Gen. Pract. 66(645), 218\u2013219. https:\/\/doi.org\/10.3399\/bjgp16X684733 (2016).","journal-title":"Br. J. Gen. Pract."},{"issue":"5","key":"65265_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.17712\/nsj.2020.5.20200057","volume":"25","author":"SMA Maawali","year":"2020","unstructured":"Maawali, S. M. A., Shibani, A. Y. A., Nadeem, A. S. & Al-Salti, A. M. Guillain\u2013Barre syndrome: Demographics, clinical features, and outcome in a single tertiary care hospital, Oman. Neurosci. J. 25(5), 369\u2013374. https:\/\/doi.org\/10.17712\/nsj.2020.5.20200057 (2020).","journal-title":"Neurosci. J."},{"issue":"1","key":"65265_CR38","first-page":"21","volume":"43","author":"Z Melaku","year":"2005","unstructured":"Melaku, Z., Zenebe, G. & Bekele, A. Guillain\u2013Barr\u00e9 syndrome in Ethiopian patients. Ethiop. Med. J. 43(1), 21\u201326 (2005).","journal-title":"Ethiop. Med. J."},{"issue":"12","key":"65265_CR39","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2471\/BLT.19.248328","volume":"98","author":"Y Assefa","year":"2020","unstructured":"Assefa, Y. et al. Primary health care contributions to universal health coverage, Ethiopia. Bull. World Health Organ. 98(12), 894-905A. https:\/\/doi.org\/10.2471\/BLT.19.248328 (2020).","journal-title":"Bull. World Health Organ."},{"issue":"2","key":"65265_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143837","volume":"11","author":"N van Leeuwen","year":"2016","unstructured":"van Leeuwen, N. et al. Hospital admissions, transfers and costs of Guillain\u2013Barr\u00e9 syndrome. PLoS One 11(2), e0143837. https:\/\/doi.org\/10.1371\/journal.pone.0143837 (2016).","journal-title":"PLoS One"},{"issue":"4","key":"65265_CR41","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000576","volume":"6","author":"PR Bourque","year":"2019","unstructured":"Bourque, P. R., Brooks, J., McCudden, C. R., Warman-Chardon, J. & Breiner, A. Age matters. Neurol. Neuroimmunol. Neuroinflamm. 6(4), e576. https:\/\/doi.org\/10.1212\/NXI.0000000000000576 (2019).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"3","key":"65265_CR42","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s00415-019-09634-0","volume":"267","author":"PR Bourque","year":"2020","unstructured":"Bourque, P. R., Brooks, J., Warman-Chardon, J. & Breiner, A. Cerebrospinal fluid total protein in Guillain\u2013Barr\u00e9 syndrome variants: Correlations with clinical category, severity, and electrophysiology. J. Neurol. 267(3), 746\u2013751. https:\/\/doi.org\/10.1007\/s00415-019-09634-0 (2020).","journal-title":"J. Neurol."},{"issue":"1","key":"65265_CR43","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jneuroim.2003.11.017","volume":"148","author":"Y Nishimoto","year":"2004","unstructured":"Nishimoto, Y., Odaka, M., Hirata, K. & Yuki, N. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J. Neuroimmunol. 148(1), 200\u2013205. https:\/\/doi.org\/10.1016\/j.jneuroim.2003.11.017 (2004).","journal-title":"J. Neuroimmunol."},{"key":"65265_CR44","doi-asserted-by":"crossref","unstructured":"Guillain\u2013Barr\u00e9 syndrome in Taiwan: A clinical study of 167 patients. J. Neurol. Neurosurg. Psychiatry. https:\/\/jnnp.bmj.com\/content\/63\/4\/494 (accessed 28 Mar 2024).","DOI":"10.1136\/jnnp.63.4.494"},{"issue":"Pt 3","key":"65265_CR45","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/brain\/118.3.597","volume":"118","author":"TW Ho","year":"1995","unstructured":"Ho, T. W. et al. Guillain\u2013Barr\u00e9 syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain J. Neurol. 118(Pt 3), 597\u2013605. https:\/\/doi.org\/10.1093\/brain\/118.3.597 (1995).","journal-title":"Brain J. Neurol."},{"issue":"1","key":"65265_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4103\/0028-3886.310063","volume":"69","author":"JL Ruiz-Sandoval","year":"2021","unstructured":"Ruiz-Sandoval, J. L. et al. Clinical characteristics and predictors of short-term outcome in Mexican adult patients with Guillain\u2013Barr\u00e9 syndrome. Neurol. India 69(1), 107\u2013114. https:\/\/doi.org\/10.4103\/0028-3886.310063 (2021).","journal-title":"Neurol. India"},{"issue":"6","key":"65265_CR47","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1136\/jnnp-2017-316930","volume":"89","author":"S Liu","year":"2018","unstructured":"Liu, S. et al. Guillain\u2013Barr\u00e9 syndrome in southern China: Retrospective analysis of hospitalised patients from 14 provinces in the area south of the Huaihe River. J. Neurol. Neurosurg. Psychiatry 89(6), 618\u2013626. https:\/\/doi.org\/10.1136\/jnnp-2017-316930 (2018).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5\u20136","key":"65265_CR48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000503101","volume":"81","author":"Y Zeng","year":"2019","unstructured":"Zeng, Y. et al. Clinical features and the validation of the brighton criteria in Guillain\u2013Barr\u00e9 syndrome: Retrospective analysis of 72 hospitalized patients in three years. Eur. Neurol. 81(5\u20136), 231\u2013238. https:\/\/doi.org\/10.1159\/000503101 (2019).","journal-title":"Eur. Neurol."},{"issue":"4","key":"65265_CR49","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4103\/0972-2327.91942","volume":"14","author":"AB Netto","year":"2011","unstructured":"Netto, A. B., Taly, A. B., Kulkarni, G. B., Rao, U. G. S. & Rao, S. Mortality in mechanically ventilated patients of Guillain\u2013Barr\u00e9 syndrome. Ann. Indian Acad. Neurol. 14(4), 262\u2013266. https:\/\/doi.org\/10.4103\/0972-2327.91942 (2011).","journal-title":"Ann. Indian Acad. Neurol."},{"key":"65265_CR50","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13613-020-00742-z","volume":"10","author":"M-A Melone","year":"2020","unstructured":"Melone, M.-A. et al. Early mechanical ventilation in patients with Guillain\u2013Barr\u00e9 syndrome at high risk of respiratory failure: A randomized trial. Ann. Intensive Care 10, 128. https:\/\/doi.org\/10.1186\/s13613-020-00742-z (2020).","journal-title":"Ann. Intensive Care"},{"issue":"12","key":"65265_CR51","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1007\/s00134-006-0332-1","volume":"32","author":"D Orlikowski","year":"2006","unstructured":"Orlikowski, D. et al. Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain\u2013Barr\u00e9 syndrome. Intensive Care Med. 32(12), 1962\u20131969. https:\/\/doi.org\/10.1007\/s00134-006-0332-1 (2006).","journal-title":"Intensive Care Med."},{"key":"65265_CR52","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13728-015-0036-7","volume":"4","author":"SM Parry","year":"2015","unstructured":"Parry, S. M. & Puthucheary, Z. A. The impact of extended bed rest on the musculoskeletal system in the critical care environment. Extreme Physiol. Med. 4, 16. https:\/\/doi.org\/10.1186\/s13728-015-0036-7 (2015).","journal-title":"Extreme Physiol. Med."},{"key":"65265_CR53","first-page":"1440","volume":"39","author":"R Teasell","year":"1993","unstructured":"Teasell, R. & Dittmer, D. K. Complications of immobilization and bed rest. Part 2: Other complications. Can. Fam. Physician 39, 1440 (1993).","journal-title":"Can. Fam. Physician"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-65265-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-65265-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-65265-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T15:02:17Z","timestamp":1720191737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-65265-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["65265"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-65265-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,5]]},"assertion":[{"value":"5 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15520"}}